Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9QEJ
|
||||
| Drug Name |
2,3-Bis(2-furyl)quinoxaline-6-{1-[(2-pyridyl)methyl]aminocarbonyl}
|
||||
| Synonyms |
CHEMBL1346172
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H16N4O3
|
||||
| Canonical SMILES |
O=C(NCc1ccccn1)c2ccc3nc(c4occc4)c(nc3c2)c5occc5
|
||||
| InChI |
InChI=1S/C23H16N4O3/c28-23(25-14-16-5-1-2-10-24-16)15-8-9-17-18(13-15)27-22(20-7-4-12-30-20)21(26-17)19-6-3-11-29-19/h1-13H,14H2,(H,25,28)
|
||||
| InChIKey |
GQAIPLQSFXPSBO-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | [1587926] | ||
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Apoptosis signaling pathway | ||||
| CCKR signaling map ST | |||||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
| Validated nuclear estrogen receptor beta network | |||||
| Validated nuclear estrogen receptor alpha networke2f_pathway:E2F transcription factor network | |||||
| Direct p53 effectors | |||||
| IL6-mediated signaling events | |||||
| HIF-1-alpha transcription factor network | |||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Ovarian Infertility Genes | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Nuclear ReceptorsWP254:Apoptosis | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in leukocytes - TarBase | |||||
| Apoptosis Modulation and Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.